Method of suppressing or reducing IL-TIF-induced...

Details Method of suppressing or reducing IL-TIF-induced... Method of suppressing or reducing IL-TIF-induced...

2009-11-17

2011-10-11

Landsman, Robert (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C424S185100

Reexamination Certificate

active

08034784

ABSTRACT:
Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor16” and uses thereof.

REFERENCES:
patent: 5488032 (1996-01-01), Dower et al.
patent: 5965704 (1999-10-01), Lok et al.
patent: 6274710 (2001-08-01), Dumoutier et al.
patent: 6740520 (2004-05-01), Goddard et al.
patent: 6897292 (2005-05-01), Presnell et al.
patent: 7189839 (2007-03-01), Presnell et al.
patent: 7265203 (2007-09-01), Presnell et al.
patent: 7351555 (2008-04-01), Presnell et al.
patent: 7615611 (2009-11-01), Presnell et al.
patent: 7638602 (2009-12-01), Presnell et al.
patent: 2003/0064473 (2003-04-01), Baker et al.
patent: 2003/0068778 (2003-04-01), Baker et al.
patent: 2003/0073188 (2003-04-01), Baker et al.
patent: 2003/0073189 (2003-04-01), Baker et al.
patent: 2003/0073191 (2003-04-01), Baker et al.
patent: 2003/0073195 (2003-04-01), Baker et al.
patent: 2003/0077741 (2003-04-01), Baker et al.
patent: 2003/0077742 (2003-04-01), Baker et al.
patent: 2003/0077743 (2003-04-01), Baker et al.
patent: 2003/0077744 (2003-04-01), Baker et al.
patent: 2003/0078401 (2003-04-01), Baker et al.
patent: 2003/0082733 (2003-05-01), Baker et al.
patent: 2003/0096363 (2003-05-01), Baker et al.
patent: 2003/0096364 (2003-05-01), Baker et al.
patent: 2003/0104559 (2003-06-01), Baker et al.
patent: 2003/0104560 (2003-06-01), Baker et al.
patent: 2003/0104561 (2003-06-01), Baker et al.
patent: 2003/0104562 (2003-06-01), Baker et al.
patent: 2003/0104563 (2003-06-01), Baker et al.
patent: 2003/0104564 (2003-06-01), Baker et al.
patent: 2003/0104565 (2003-06-01), Baker et al.
patent: 2003/0104566 (2003-06-01), Baker et al.
patent: 2003/0108996 (2003-06-01), Baker et al.
patent: 2003/0119086 (2003-06-01), Baker et al.
patent: 2003/0119113 (2003-06-01), Baker et al.
patent: 2003/0119114 (2003-06-01), Baker et al.
patent: 2003/0119115 (2003-06-01), Baker et al.
patent: 2003/0119116 (2003-06-01), Baker et al.
patent: 2003/0119117 (2003-06-01), Baker et al.
patent: 2003/0119118 (2003-06-01), Baker et al.
patent: 2003/0119119 (2003-06-01), Baker et al.
patent: 2003/0119120 (2003-06-01), Baker et al.
patent: 2003/0119121 (2003-06-01), Baker et al.
patent: 2003/0119122 (2003-06-01), Baker et al.
patent: 2003/0119123 (2003-06-01), Baker et al.
patent: 2003/0119124 (2003-06-01), Baker et al.
patent: 2003/0119125 (2003-06-01), Baker et al.
patent: 2003/0119126 (2003-06-01), Baker et al.
patent: 2003/0119127 (2003-06-01), Baker et al.
patent: 2003/0119128 (2003-06-01), Baker et al.
patent: 2003/0119129 (2003-06-01), Baker et al.
patent: 2003/0119130 (2003-06-01), Baker et al.
patent: 2003/0119131 (2003-06-01), Baker et al.
patent: 2003/0119132 (2003-06-01), Baker et al.
patent: 2003/0119133 (2003-06-01), Baker et al.
patent: 2003/0119134 (2003-06-01), Baker et al.
patent: 2003/0119135 (2003-06-01), Baker et al.
patent: 2003/0119136 (2003-06-01), Baker et al.
patent: 2003/0119137 (2003-06-01), Baker et al.
patent: 2003/0119138 (2003-06-01), Baker et al.
patent: 2003/0119139 (2003-06-01), Baker et al.
patent: 2003/0119140 (2003-06-01), Baker et al.
patent: 2003/0119141 (2003-06-01), Baker et al.
patent: 2003/0119142 (2003-06-01), Baker et al.
patent: 2003/0119143 (2003-06-01), Baker et al.
patent: 2003/0124663 (2003-07-01), Baker et al.
patent: 2003/0124665 (2003-07-01), Baker et al.
patent: 2003/0124666 (2003-07-01), Baker et al.
patent: 2003/0124667 (2003-07-01), Baker et al.
patent: 2003/0138896 (2003-07-01), Baker et al.
patent: 2003/0138897 (2003-07-01), Baker et al.
patent: 2003/0138898 (2003-07-01), Baker et al.
patent: 2003/0138899 (2003-07-01), Baker et al.
patent: 2003/0138900 (2003-07-01), Baker et al.
patent: 2003/0138901 (2003-07-01), Baker et al.
patent: 2003/0138902 (2003-07-01), Baker et al.
patent: 2007/0106068 (2007-05-01), Presnell et al.
patent: 2007/0122883 (2007-05-01), Presnell et al.
patent: 2007/0134237 (2007-06-01), Presnell et al.
patent: 2007/0134745 (2007-06-01), Presnell et al.
patent: 2007/0135347 (2007-06-01), Presnell et al.
patent: 2007/0148143 (2007-06-01), Presnell et al.
patent: 2007/0166746 (2007-07-01), Presnell et al.
patent: 2008/0214785 (2008-09-01), Presnell et al.
patent: 2008/0242839 (2008-10-01), Presnell et al.
patent: 1191035 (2002-03-01), None
patent: 98/02542 (1998-01-01), None
patent: 98/37193 (1998-08-01), None
patent: 99/07848 (1999-02-01), None
patent: 00/24758 (2000-05-01), None
patent: 00/39161 (2000-07-01), None
patent: 00/65027 (2000-11-01), None
patent: 00/70049 (2000-11-01), None
patent: 00/73457 (2000-12-01), None
patent: 00/77037 (2000-12-01), None
patent: 01/16318 (2001-03-01), None
patent: 01/36467 (2001-05-01), None
patent: 01/40467 (2001-06-01), None
patent: 01/46422 (2001-06-01), None
patent: 01/98342 (2001-12-01), None
patent: 02/20569 (2002-03-01), None
patent: 02/24912 (2002-03-01), None
patent: 02/066647 (2002-08-01), None
patent: 02/072607 (2002-09-01), None
patent: 03/035096 (2003-05-01), None
patent: 03/083062 (2003-10-01), None
Ho Asy, et al. PNAS 90:11267-11271, 1993.
ATCC, “ATCC No. CRL-1927,” retrieved online at http://www.atcc.org/ATCCAdvancedCatalogSearch/ ProductDetails/tabid/452/Default.aspx2ATCCNum=CRL-1927&Template=cellBiology (2011).
Attwood, Teresa K., “The Babel of Bioinformatics,” Science, vol. 290(5491):471-473 (2000).
Blumberg, Hal et al., “Interleukin 20: Discovery, Receptor Identification, and Role in Epidermal Function,” Cell, vol. 104:9-19 (2001).
Bork, Peer et al., “Go hunting in sequence databases but watch out for the traps,” TIG, vol. 12(10):425-427 (1996).
Bork, Peer, “Powers and Pitfalls in Sequence Analysis: The 70% Hurdle,” Genome Research, vol. 10:398-400 (2000).
Bork, Peer et al., “Predicting functions from protein sequences—where are the bottlenecks?” Nature Genetics, vol. 18(4):313-318 (1998).
Camper, Lisbet et al., “Distribution of the collagen-binding integrin alpha10beta1 during mouse development,” Cell Tissue Res., vol. 306:107-116 (2001).
Dumoutier, Laure et al., “Cloning and Characterization of IL-10-Related T Cell-Derived Inducible Factor (IL-TIF), a Novel Cytokine Structurally Related to IL-10 and Inducible by IL-9,” The Journal of Immunology, vol. 164:1814-1819 (2000).
Dumoutier, Laure et al., “Cloning and Characterization of IL-22 Binding Protein, a Natural Antagonist of IL-10-Related T Cell-Derived Inducible Factor/IL-22,” The Journal of Immunology, vol. 166:7090-7095 (2001).
Dumoutier, Laure et al., “Cutting Edge: STAT Activation by IL-19, IL-20 and mda-7 Through IL-20 Receptor Complexes of Two Types,” The Journal of Immunology, vol. 167:3545-3549 (2001).
Dumoutier, Laure et al., “Human interleukin-10-related T cell-derived inducible factor: Molecular cloning and functional characterization as an hepatocyte-stimulating factor,” PNAS, vol. 97(18):10144-10149 (2000).
Dumoutier, L. et al., “IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes,” Genes and Immunity, vol. 1:488-494 (2000).
Fickenscher, Helmut et al., “The interleukin-10 family of cytokines,” Trends in Immunology, vol. 23(2):89-96 (2002).
GenBank Accession No. AL050337 (2009).
GenBank Accession No. AA132964 (2011).
GenBank Accession No. AC007458 (2003).
GenBank Accession No. AV714177 (2000).
GenBank Accession No. T70354 (1995).
GenBank Accession No. T70439 (1995).
Gruenberg, B.H. et al., “A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta,” Genes and Immunity, vol. 2:329-334 (2001).
Gurney, Austin et al., “IL-22, a Novel Human Cytokine that Signals Through the Interferon Receptor Related Proteins CRF2-4 and IL-22R,” Eur. Cytokine Netw., vol. 11:39, No. 05002 (2000).
Kotenko, Sergei V. et al., “Identification, Cloning, and Characterization of a Novel Soluble Receptor That Binds IL-22 and Neutralizes Its Activity,” The Journal of Immun

Affiliated with

Also associated with

Rating

Method of suppressing or reducing IL-TIF-induced... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of suppressing or reducing IL-TIF-induced..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of suppressing or reducing IL-TIF-induced... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4269009